Diffuse large B cell lymphoma coexistence with systemic mastocytosis
Journal of Cancer Research and Practice, 2016 Systemic mastocytosis is a rare disease and characterized by excessive mast cell accumulation in one or multiple organs. One subtype of systemic mastocytosis is systemic mastocytosis-associated clonal hematological non-mast cell lineage disease (SM-AHMND)
Sheng-Hsuan Chien +8 more
doaj +2 more sources
French guidelines for the management of nonadvanced mastocytosis in adults [PDF]
Orphanet Journal of Rare DiseasesMastocytosis is a rare disease caused by abnormal mast cell accumulation/proliferation in various organs/tissues. Its clinical features exhibit significant variability irrespective of its clinical presentation, classification, global survival or impact ...
Cristina Bulai Livideanu +5 more
doaj +2 more sources
Multifocal colonic mastocytosis mimicking ischaemic colitis: a rare cause of lower gastrointestinal bleeding [PDF]
European Journal of Case Reports in Internal MedicineIntroduction: Mastocytosis is a rare clonal disorder characterised by abnormal proliferation and accumulation of mast cells in one or more organs. Although gastrointestinal symptoms are common in systemic mastocytosis, direct mucosal infiltration by ...
Karam Karam +4 more
doaj +2 more sources
Case Report: Treatment of systemic mastocytosis with sunitinib [version 1; referees: 2 approved]
F1000Research, 2017 Mast cell activation disease typically presents as chronic multisystem polymorbidity of generally inflammatory ± allergic theme. Presently, treatment of the rare, cytoproliferative variant systemic mastocytosis employs empirically selected therapies to ...
Gerhard J. Molderings +3 more
doaj +2 more sources
Chronic Anaphylaxis With Indolent Systemic Mastocytosis: A Case Report
Case Reports in HematologySystemic mastocytosis is a rare, clonal mast cell disease neoplasm driven by the KIT D816V mutation in greater than 95% of cases. The complex clinical presentation of systemic mastocytosis can make diagnosis challenging.
Sarah Worth +4 more
doaj +2 more sources
Zdorovʹe Rebenka, 2022 Background. Mastocytosis is a disease characterized by the presence of mast cells in various organs. The skin is affected most often. Almost every patient diagnosed with mastocytosis has skin lesions.
O.L. Statkevych, T.V. Sviatenko
doaj +1 more source
Safety Practices During Hymenoptera Venom Immunotherapy: Single-Centre Experience With Protocolised Intravenous Cannulation and Adrenaline Usage. [PDF]
AllergyAllergy, Volume 81, Issue 6, Page 2212-2214, June 2026.
McWaters C +4 more
europepmc +2 more sources
Increased TIM-3 and GAL-9 serum levels in patients with advanced systemic mastocytosis. [PDF]
, 2023 BACKGROUND Systemic mastocytosis is characterized by expansion of clonal mast cells in various tissues. Several biomarkers with diagnostic and therapeutic potential have recently been characterized in mastocytosis, such as the serum marker tryptase ...
Peter Valent +19 more
core +1 more source
Italian Journal of Pediatrics, 2023 Background Pediatric Mastocytosis is a rare and heterogeneous disease, characterized by accumulation of mast cells in the skin (Cutaneous Mastocytosis) and/or, less frequently, in other organs, mainly liver, spleen, bone marrow, lymph nodes and ...
Grazia Bossi +9 more
doaj +1 more source
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study [PDF]
, 2021 [Background]: Several risk stratification models have been proposed in recent years for systemic mastocytosis but have not been directly compared. Here we designed and validated a risk stratification model for progression-free survival (PFS) and overall ...
Cecelia Perkins +71 more
core +1 more source